Breaking News Instant updates and real-time market news.

APHA

Aphria

$6.21 /

+0.04 (+0.65%)

04:55
08/20/19
08/20
04:55
08/20/19
04:55

Aphria management to meet with Seaport Global

Meetings to be held in Denver on August 19-20 hosted by Seaport Global.

  • 20

    Aug

APHA Aphria
$6.21 /

+0.04 (+0.65%)

07/26/19 CIBC
Aphria downgraded to Underperformer from Neutral at CIBC
06/10/19 Piper Sandler
Cannabis regulation could become top 2020 election issue, says Piper Jaffray
05/24/19
Fly Intel: Top five analyst initiations
05/24/19 Jefferies
Jefferies starts Aphria at Buy, says valuation 'not reflective of reality'

TODAY'S FREE FLY STORIES

Hot Stocks
Pieris Pharmaceuticals, Eli Lilly enter into clinical trial collaboration » 06:55
08/10/20
08/10
06:55
08/10/20
06:55
PIRS

Pieris Pharmaceuticals

$2.68 /

-0.06 (-2.19%)

, LLY

Eli Lilly

$152.89 /

+0.01 (+0.01%)

Pieris Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

07/31/20 Barclays
Eli Lilly earnings selloff 'meaningful over-reaction,' says Barclays
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

Earnings
Granite reports $463.6M of available liquidity at end of Q2 » 06:54
08/10/20
08/10
06:54
08/10/20
06:54
GVA

Granite Construction

$18.92 /

+0.775 (+4.27%)

The copany said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

06/25/20 DA Davidson
Granite Construction price target lowered to $17 from $30 at DA Davidson
01/13/20 Goldman Sachs
Granite Construction downgraded to Sell from Neutral at Goldman Sachs
10/28/19
Granite Construction downgraded to Neutral from Buy at DA Davidson
10/28/19 DA Davidson
Granite Construction downgraded to Neutral from Buy at DA Davidson
GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

Hot Stocks
Virtu Financial names Sean Galvin as new CFO, succeeding Alex Ioffe » 06:54
08/10/20
08/10
06:54
08/10/20
06:54
VIRT

Virtu Financial

$22.81 /

-1.8 (-7.31%)

Virtu Financial announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

06:34 Today Piper Sandler
Virtu Financial sell-off 'unwarranted,' says Piper Sandler
05/08/20 Compass Point
Virtu Financial price target raised to $28 from $23.50 at Compass Point
04/16/20 Rosenblatt
Virtu Financial downgraded to Neutral from Buy at Rosenblatt
03/04/20 JPMorgan
Virtu Financial price target raised to $23 from $20 at JPMorgan
VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

Earnings
Foot Locker not providing FY20 guidance at this time » 06:53
08/10/20
08/10
06:53
08/10/20
06:53
FL

Foot Locker

$27.49 /

+0.54 (+2.00%)

Foot Locker said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

07/21/20 Deutsche Bank
Foot Locker named 'Short-Term Catalyst Buy Idea' at Deutsche Bank
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 Susquehanna
Foot Locker upgraded to Positive from Neutral at Susquehanna
06/22/20
Fly Intel: Top five analyst downgrades
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

Hot Stocks
Foot Locker reports Q2 SSS up 18%  06:52
08/10/20
08/10
06:52
08/10/20
06:52
FL

Foot Locker

$27.49 /

+0.54 (+2.00%)

 
ShowHide Related Items >><<
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

07/21/20 Deutsche Bank
Foot Locker named 'Short-Term Catalyst Buy Idea' at Deutsche Bank
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 Susquehanna
Foot Locker upgraded to Positive from Neutral at Susquehanna
06/22/20
Fly Intel: Top five analyst downgrades
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

Earnings
Foot Locker sees Q2 EPS ex-itesm 66c-70c vs. 66c last year » 06:52
08/10/20
08/10
06:52
08/10/20
06:52
FL

Foot Locker

$27.49 /

+0.54 (+2.00%)

Foot Locker provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

07/21/20 Deutsche Bank
Foot Locker named 'Short-Term Catalyst Buy Idea' at Deutsche Bank
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 Susquehanna
Foot Locker upgraded to Positive from Neutral at Susquehanna
06/22/20
Fly Intel: Top five analyst downgrades
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

Downgrade
OpenText downgraded to Sell from Buy at Veritas » 06:52
08/10/20
08/10
06:52
08/10/20
06:52
OTEX

OpenText

$45.77 /

-0.525 (-1.13%)

Veritas analyst Howard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTEX OpenText
$45.77 /

-0.525 (-1.13%)

OTEX OpenText
$45.77 /

-0.525 (-1.13%)

05/01/20 TD Securities
OpenText price target raised to C$47 from C$45 at TD Securities
05/01/20 BMO Capital
BMO raises OpenText price target to C$61 after Q3 results
05/01/20 RBC Capital
OpenText's Q3 'effectively in line' with pre-COVID-19 estimates, says RBC
04/27/20 RBC Capital
OpenText price target lowered to $45 from $54 at RBC Capital
OTEX OpenText
$45.77 /

-0.525 (-1.13%)

OTEX OpenText
$45.77 /

-0.525 (-1.13%)

Hot Stocks
Synchronoss announces contract renewal with Verizon » 06:52
08/10/20
08/10
06:52
08/10/20
06:52
SNCR

Synchronoss

$3.08 /

+0.02 (+0.65%)

, VZ

Verizon

$58.52 /

+0.69 (+1.19%)

Synchronoss (SNCR)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
05/26/20 Northland
Synchronoss initiated with an Outperform at Northland
05/11/20 Roth Capital
Synchronoss price target lowered to $9 from $13 at Roth Capital
12/20/19 Roth Capital
Roth says Synchronoss opportunity in advanced messaging looks underappreciated
VZ Verizon
$58.52 /

+0.69 (+1.19%)

07/20/20 Needham
Infinera likely to join Ciena supplying 800G for Verizon, says Needham
07/08/20 JPMorgan
Nokia downgraded to Neutral from Overweight at JPMorgan
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/11/20 Wells Fargo
T-Mobile price target raised to $120 from $110 at Wells Fargo
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

Upgrade
Adient upgraded to Buy from Hold at Benchmark » 06:51
08/10/20
08/10
06:51
08/10/20
06:51
ADNT

Adient

$15.29 /

-0.385 (-2.46%)

Benchmark analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$15.29 /

-0.385 (-2.46%)

ADNT Adient
$15.29 /

-0.385 (-2.46%)

06:24 Today Benchmark
Adient upgraded to Buy from Hold at Benchmark
06/19/20 JPMorgan
Adient price target raised to $13 from $11 at JPMorgan
05/06/20
Fly Intel: Top five analyst upgrades
05/06/20 KeyBanc
Adient upgraded to Overweight from Sector Weight at KeyBanc
ADNT Adient
$15.29 /

-0.385 (-2.46%)

ADNT Adient
$15.29 /

-0.385 (-2.46%)

Hot Stocks
Reata Pharmaceuticals says pre-NDA meeting granted for Bardoxolone » 06:50
08/10/20
08/10
06:50
08/10/20
06:50
RETA

Reata Pharmaceuticals

$157.16 /

+5.07 (+3.33%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG
05/18/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $275 from $270 at Cantor Fitzgerald
04/17/20 Jefferies
Reata Pharmaceuticals price target raised to $348 from $335 at Jefferies
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

  • 14
    Nov
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

Recommendations
Installed Building Products price target raised to $104 from $87 at Benchmark » 06:50
08/10/20
08/10
06:50
08/10/20
06:50
IBP

Installed Building Products

$85.92 /

+0.82 (+0.96%)

Benchmark analyst Reuben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

08/07/20 Zelman
Installed Building Products upgraded to Buy from Hold at Zelman
07/16/20 BTIG
Installed Building Products, Builders FirstSource price targets raised at BTIG
07/08/20 SunTrust
SunTrust ups Installed Building Products, TopBuild, Builders FirstSource targets
06/18/20 Benchmark
Installed Building Products price target raised to $87 from $63 at Benchmark
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

Earnings
Zynerba reports Q2 EPS (78c), consensus (45c) » 06:49
08/10/20
08/10
06:49
08/10/20
06:49
ZYNE

Zynerba

$4.20 /

-0.08 (-1.87%)

As of June 30 cash and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

Upgrade
CF Industries upgraded to Buy from Neutral at Citi » 06:49
08/10/20
08/10
06:49
08/10/20
06:49
CF

CF Industries

$33.13 /

-0.26 (-0.78%)

Citi analyst P.J. Juvekar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

08/07/20
Fly Intel: Top five analyst upgrades
08/07/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
08/07/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
07/13/20
Fly Intel: Top five analyst upgrades
CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

Initiation
GoHealth initiated with an Outperform at RBC Capital » 06:48
08/10/20
08/10
06:48
08/10/20
06:48
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

RBC Capital analyst Frank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
06:24 Today BofA
GoHealth initiated with a Buy at BofA
06:22 Today Truist
GoHealth initiated with a Buy at Truist
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Earnings
Reata Pharmaceuticals reports Q2 adjusted EPS ($1.23), consensus ($2.84) » 06:47
08/10/20
08/10
06:47
08/10/20
06:47
RETA

Reata Pharmaceuticals

$157.16 /

+5.07 (+3.33%)

Reports Q2 collaboration…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG
05/18/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $275 from $270 at Cantor Fitzgerald
04/17/20 Jefferies
Reata Pharmaceuticals price target raised to $348 from $335 at Jefferies
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

  • 14
    Nov
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

Earnings
Target Hospitality reports Q2 EPS (15c), consensus (11c) » 06:46
08/10/20
08/10
06:46
08/10/20
06:46
TH

Target Hospitality

$1.45 /

-0.04 (-2.68%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TH Target Hospitality
$1.45 /

-0.04 (-2.68%)

TH Target Hospitality
$1.45 /

-0.04 (-2.68%)

04/01/20 Northland
Northland downgrades Target Hospitality on oil market deterioration
04/01/20 Northland
Target Hospitality downgraded to Market Perform from Outperform at Northland
03/10/20 Stifel
Target Hospitality downgraded to Hold from Buy at Stifel
02/28/20 Deutsche Bank
Target Hospitality downgraded to Hold from Buy at Deutsche Bank
TH Target Hospitality
$1.45 /

-0.04 (-2.68%)

Downgrade
Rayonier downgraded to Neutral from Buy at Citi » 06:46
08/10/20
08/10
06:46
08/10/20
06:46
RYN

Rayonier

$28.10 /

-0.205 (-0.72%)

Citi analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYN Rayonier
$28.10 /

-0.205 (-0.72%)

RYN Rayonier
$28.10 /

-0.205 (-0.72%)

03/27/20 Citi
Rayonier upgraded to Buy from Neutral at Citi
01/07/20 Raymond James
Timber REIT sector upgraded to Overweight from Market Weight at Raymond James
11/01/19 DA Davidson
Rayonier upgraded to Buy from Neutral at DA Davidson
11/01/19 DA Davidson
Rayonier upgraded to Buy from Neutral at DA Davidson
RYN Rayonier
$28.10 /

-0.205 (-0.72%)

Initiation
GoHealth initiated with an Overweight at Cantor Fitzgerald » 06:45
08/10/20
08/10
06:45
08/10/20
06:45
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
06:24 Today BofA
GoHealth initiated with a Buy at BofA
06:22 Today Truist
GoHealth initiated with a Buy at Truist
06:08 Today Barclays
GoHealth initiated with an Overweight at Barclays
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Upgrade
TopBuild upgraded to Buy from Neutral at BTIG » 06:45
08/10/20
08/10
06:45
08/10/20
06:45
BLD

TopBuild

$141.82 /

+2.61 (+1.87%)

BTIG analyst Ryan Gilbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLD TopBuild
$141.82 /

+2.61 (+1.87%)

BLD TopBuild
$141.82 /

+2.61 (+1.87%)

06:37 Today Stephens
TopBuild price target raised to $150 from $100 at Stephens
06:33 Today BTIG
TopBuild upgraded to Buy from Neutral at BTIG
08/05/20 Credit Suisse
TopBuild price target raised to $176 from $149 at Credit Suisse
08/05/20 Deutsche Bank
TopBuild price target raised to $160 from $130 at Deutsche Bank
BLD TopBuild
$141.82 /

+2.61 (+1.87%)

General news
FX Update: The dollar has traded moderately firmer » 06:45
08/10/20
08/10
06:45
08/10/20
06:45

FX Update: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
OraSure initiated with a Buy at Citi » 06:44
08/10/20
08/10
06:44
08/10/20
06:44
OSUR

OraSure

$14.04 /

+0.95 (+7.26%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSUR OraSure
$14.04 /

+0.95 (+7.26%)

OSUR OraSure
$14.04 /

+0.95 (+7.26%)

06:11 Today JPMorgan
OraSure initiated with a Neutral at JPMorgan
08/07/20 Raymond James
OraSure upgraded to Outperform from Market Perform at Raymond James
08/07/20 Raymond James
OraSure upgraded to Outperform from Market Perform at Raymond James
06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
OSUR OraSure
$14.04 /

+0.95 (+7.26%)

  • 03
    Jun
OSUR OraSure
$14.04 /

+0.95 (+7.26%)

Recommendations
Waste Connections price target raised to $115 from $110 at Stifel » 06:42
08/10/20
08/10
06:42
08/10/20
06:42
WCN

Waste Connections

$101.85 /

-1.36 (-1.32%)

Stifel analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

08/07/20 UBS
Waste Connections price target raised to $116 from $108 at UBS
07/20/20 KeyBanc
Waste Connections price target raised to $115 from $105 at KeyBanc
07/10/20 BMO Capital
Waste Connections price target raised to $106 from $104 at BMO Capital
07/01/20 Jefferies
GFL Environmental initiated with a Buy at Jefferies
WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

Hot Stocks
LogicBio Therapeutics announces clinical trial design for LB-001 » 06:41
08/10/20
08/10
06:41
08/10/20
06:41
LOGC

LogicBio Therapeutics

$7.88 /

+0.13 (+1.68%)

LogicBio Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

01/10/20 Roth Capital
LogicBio reported 'two wins' with updates, says Roth Capital
LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

Hot Stocks
Seres Therapeutics soars 170% after 'positive' results from Phase 3 ECOSPOR III » 06:41
08/10/20
08/10
06:41
08/10/20
06:41
MCRB

Seres Therapeutics

$4.65 /

+0.22 (+4.97%)

In pre-market trading,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCRB Seres Therapeutics
$4.65 /

+0.22 (+4.97%)

MCRB Seres Therapeutics
$4.65 /

+0.22 (+4.97%)

Recommendations
TripAdvisor price target raised to $21 from $15 at Stifel » 06:41
08/10/20
08/10
06:41
08/10/20
06:41
TRIP

TripAdvisor

$21.07 /

-0.55 (-2.54%)

Stifel analyst Logan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

07/29/20 Jefferies
Booking Holdings price target raised to $1,600 from $1,300 at Jefferies
06/23/20 RBC Capital
TripAdvisor's Q2 update implies sequential improvement, says RBC Capital
06/10/20 BTIG
TripAdvisor initiated with a Neutral at BTIG
05/11/20 Credit Suisse
TripAdvisor price target lowered to $22 from $28 at Credit Suisse
TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.